SPC
EBS icon

Sigma Planning Corp’s Emergent Biosolutions EBS Stock Holding History

Sigma Planning Corp’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,981
Closed -$556K – 1435
2021
Q1 		$556K Sell
5,981
-266
-4% -$27.2K 0.02% 725
2020
Q4 		$560K Buy
6,247
+920
+17% +$84.4K 0.02% 654
2020
Q3 		$550K Sell
5,327
-321
-6% -$34.6K 0.02% 573
2020
Q2 		$447K Buy
+5,648
New +$421K 0.02% 630

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sigma Planning Corp's EBS Position: Q2 2021 in Review

Sigma Planning Corp sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 5,981 shares — an estimated $556K sold.

Sigma Planning Corp first reported a position in EBS in Q2 2020 and held it in 4 quarters. The position peaked at $560K in Q4 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Sigma Planning Corp reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Sigma Planning Corp sold 5,981 Emergent Biosolutions shares in Q2 2021, an estimated $556K.
  • Sigma Planning Corp first reported a position in Emergent Biosolutions in Q2 2020 and held it in 4 quarters.
  • Sigma Planning Corp's Emergent Biosolutions position peaked at $560K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Sigma Planning Corp's 13F filing for Q2 2021, filed 13 Aug 2021.